Evidence map›Paper›PMID 38222048›Full record

ArticleNeuro-oncology practice2024

Gender balance and suitable positive actions to promote gender equality among healthcare professionals in neuro-oncology: The EANO positive action initiative.

Emilie Le Rhun, Florien Boele, Giuseppe Minniti, Norbert Galldiks, Martin Taphoorn, Karin Piil, Roberta Rudà, Simone P Niclou, Marjolein Geurts, Matthias Preusser and 3 more

Open access · hybridAbstract read
In one paragraph

Article in Neuro-oncology practice, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
2.3field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 5 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Towards gender equity in neuro-oncology.Neuro-oncology practice · 2024
    Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 10 institutions in 8 countries.

Emilie Le RhunDepartments of Neurosurgery, Clinical Neuroscience Center, University Hospital and University of Zurich, Zurich, Switzerland.ORCID https://orcid.org/0000-0002-9408-3278
Florien BoeleLeeds Institute of Medical Research at St James's, St James's University Hospital, University of Leeds, Leeds, UK.ORCID https://orcid.org/0000-0003-0409-7949
Giuseppe MinnitiDepartment of Radiological Sciences, Oncology, and Anatomical Pathology, Sapienza University of Rome, Rome, Italy.
Norbert GalldiksDepartment of Neurology, Faculty of Medicine, University Hospital Cologne, University of Cologne, Cologne, Germany.ORCID https://orcid.org/0000-0002-2485-1796
Martin TaphoornDepartment of Neurology, Leiden University Medical Center, Leiden, The Netherlands.ORCID https://orcid.org/0000-0001-9949-4722
Karin PiilDepartment of Oncology, Centre for Cancer and Organ Diseases, Copenhagen University Hospital, Rigshospitalet, Copenhagen, Denmark.ORCID https://orcid.org/0000-0001-7972-4674
Roberta RudàDivision of Neuro-Oncology, Department of Neuroscience, University of Turin, Turin, Italy.
Simone P NiclouDepartment of Cancer Research, Luxembourg Institute of Health, Strassen, Luxembourg.ORCID https://orcid.org/0000-0002-3417-9534
Marjolein GeurtsThe Brain Tumour Center at the Erasmus MC Cancer Institute, Rotterdam, The Netherlands.ORCID https://orcid.org/0000-0003-2369-0035
Matthias PreusserDivision of Oncology, Department of Medicine 1, Medical University, Vienna, Austria.ORCID https://orcid.org/0000-0003-3541-2315
Michael WellerDepartment of Neurology, Clinical Neuroscience Center, University Hospital and University of Zurich, Zurich, Switzerland.ORCID https://orcid.org/0000-0002-1748-174X
Susan C ShortLeeds Institute of Medical Research, University of Leeds, Leeds, UK.
Linda DirvenDepartment of Neurology, Leiden University Medical Center, Leiden, The Netherlands.ORCID https://orcid.org/0000-0001-9157-9895
Leiden University Medical Center · NLUniversity of Leeds · GBUniversity of Zurich · CHErasmus MC Cancer Institute · NLForschungszentrum Jülich · DEIstituto Neurologico Mediterraneo · ITMedical University of Vienna · ATRoskilde University · DKUniversity of Luxembourg · LUUniversity of Turin · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: The proportion of women among healthcare and biomedical research professionals in neuro-oncology is growing. With changes in cultural expectations and work-life balance considerations, more men aspire to nonfull-time jobs, yet, leadership positions remain dominated by men. Methods: The European Association of Neuro-Oncology (EANO) disparity committee carried out a digital survey to explore gender balance and actions suitable to promote gender equality. The survey was distributed among EANO members in 2021, with responses analyzed descriptively. Results: In total, 262 participants completed the survey (141 women, 53.8%; median age 43). Respondents were neurosurgeons (68, 26.0%); neurologists (67, 25.6%), medical oncologists (43, 16.4%), or other healthcare or research professionals; 208 participants (79.4%) worked full-time. Positive action to enforce the role of women in neuro-oncology was deemed necessary by 180 participants (68.7%), but only 28 participants (10.7%) agreed that Conclusions: Specific indicators may help to measure and promote gender balance and should be considered for implementation among healthcare professionals in neuro-oncology.

Indexed as

DiscriminationDisparityFemaleIndicatorMale

Identifiers

PMID38222048
PMCPMC10785600
OpenAlexW4387341790

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.